Webinar: ACR/CHEST ILD Guidelines in Practice| Video: COVID in the Rear View

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

RA: How High Is the Toll?

  |  Issue: February 2025  |  

Dr. Shapiro

Samantha C. Shapiro, MD, is a clinician educator who is passionate about the care and education of rheumatology patients. She writes for both medical and lay audiences and practices telerheumatology.

References

  1. Huang Y, Li J, Agarwal SK. Economic and humanistic burden of rheumatoid arthritis: Results from the US national survey data 2018–2020. ACR Open Rheumatol. 2024 Nov;6(11):746–754.
  2. Finckh A, Gilbert B, Hodkinson B, et al. Global epidemiology of rheumatoid arthritis. Nat Rev Rheumatol. 2022 Oct;18(10):591–602.
  3. Lexchin J. Affordable biologics for all. JAMA Netw Open. 2020 Apr 1;3(4):e204753.
  4.  Hresko A, Lin TC, Solomon DH. Medical care costs associated with rheumatoid arthritis in the US: A systematic literature review and meta-analysis. Arthritis Care Res (Hoboken). 2018 Oct;70(10):1431–1438.
  5. Ma VY, Chan L, Carruthers KJ. Incidence, prevalence, costs, and impact on disability of common conditions requiring rehabilitation in the United States: Stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, osteoarthritis, rheumatoid arthritis, limb loss, and back pain. Arch Phys Med Rehabil. 2014 May;95(5):986–995.e1.
  6. Kim JW, Suh CH. Systemic manifestations and complications in patients with rheumatoid arthritis. J Clin Med. 2020 Jun 26;9(6):2008.
  7.  Goma SH, Razek MRA, Abdelbary NM. Impact of rheumatoid arthritis on the quality of life and its relation to disease activity. Egyptian Rheumatology and Rehabilitation. 2019;46(4):304–312.
  8. Chen CI, Wang L, Wei W, Yuce H, Phillips K. Burden of rheumatoid arthritis among US Medicare population: Co-morbidities, health-care resource utilization and costs. Rheumatol Adv Pract. 2018 Feb 21;2(1):rky005.
  9. Roodenrijs NMT, Welsing PMJ, Van Der Goes MC, et al. Healthcare utilization and economic burden of difficult-to-treat rheumatoid arthritis: A cost-of-illness study. Rheumatology (Oxford). 2021 Oct;60(10):4681–4690.
  10. Tatangelo M, Tomlinson G, Paterson JM, et al. Health care costs of rheumatoid arthritis: A longitudinal population study. PLoS One. 2021 May 6;16(5):e0251334.
  11. Cohen JW, Cohen SB, Banthin JS. The medical expenditure panel survey: A national information resource to support healthcare cost research and inform policy and practice. Med Care. 2009 Jul;47(7 Suppl 1):S44–S50.

Related Articles

    Physical Activity, Exercise Can Benefit Patients with RA

    While medical advances in rheumatoid arthritis (RA) have led to improvements in disease control and quality of life for patients worldwide, the rate for stable remission remains low.1 Management of RA symptoms is traditionally accomplished through a combination of medications and nonpharmacological interventions.2 This approach can prevent the development of secondary adverse health outcomes. Two…

    Outpatient Medicine in the Post-COVID-19 Era of Telemedicine

    Our hospitals have had their finest hour in the care of acutely ill inpatients during the COVID-19 pandemic, including dealing with allocation decisions fairly and transparently, maximizing good outcomes and remaining cognizant of the enduring ethics of healthcare. The honorable traditions of self-effacing conduct and acceptance of some level of personal risk by healthcare professionals…

    Pharmaceutical Care Models, Tools for Treating Patients with Rheumatoid Arthritis

    Rheumatoid arthritis (RA) can be defined as a chronic autoimmune systemic inflammatory condition characterized by symmetrical polyarthritis. Typically, patients present with pain, stiffness and warmth of the affected joints. The condition can result in extra-articular features, adding to disability, and may eventually lead to premature death, especially if not treated early and appropriately.1,2 Over the…